ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

EMBC vs OFIX // FORWARD P/E MULTIPLE

Embecta Corp. (NASDAQ) VS. Orthofix Medical Inc. (NASDAQ) • 15-METRIC TALLY: EMBC 5 — OFIX 3
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMBC VS. OFIX) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC EMBC OFIX SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 62.60% 68.80% -6.20 OFIX /gross-margins <GO>
Return on Invested Capital (ROIC) 35.50% -12.20% +47.70 EMBC /roic <GO>
EV/EBITDA & P/E Valuation 6.1x — — TIE /valuation <GO>
Free Cash Flow Yield — 7.99% — TIE /fcf-yield <GO>
Operating Margin 22.40% -9.90% +32.30 EMBC /operating-margins <GO>
Net Profit Margin 8.80% -11.20% +20.00 EMBC /net-margins <GO>
Revenue Growth (YoY) -3.80% 2.90% -6.70 OFIX /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 9.42% 0.00% +9.42 EMBC /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 1.02 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 7/9 7/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 51.2 44.8 +6.40 EMBC /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple ACTIVE 3.6x — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $354.1M $369.4M -$15.3M OFIX /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR EMBC REV OFIX REV EMBC GROSS % OFIX GROSS % EMBC FCF OFIX FCF
FY 2025 $1.08B $822.3M 62.6% 68.8% $182.4M $33.3M
FY 2024 $1.12B $799.5M 65.5% 68.3% $19.9M $25.8M
FY 2023 $1.12B $746.6M — — $67.7M -$45.8M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMBC // BETA —
OFIX // BETA —